Now free: Conference on Breathing Additional Life into the Life Sciences
Thanks to a new sponsor, Breathing Additional Life into the Life Sciences is now free.
Reaching the Next Milestone
Conference on Breathing Additional Life into the Life Sciences
Date: Friday, November 4, 2011 Time: 7:30 AM to 3:00 PM
Purpose of Conference
The future for life science companies is extremely promising, full of enormous opportunities. However, life science companies face ever increasing challenges, from finding seed money, finding venture or angel investor funding, dealing with universities or the Federal Government, protecting their intellectual property and resolving IP related disputes, determining specific technologies needed for growth or seeking potential licensees, to making financial decisions regarding various courses of action.
This conference is designed for biotechnology/pharmaceutical company decision makers in enabling them to reach the next milestone, no matter what stage their company is in presently. The conference deals with addressing attracting funding, making technology based decisions, and protecting their intellectual property, to best capitalize on their efforts. University technology transfer attorneys, government attorneys and others stand to benefit from attending as well.
Our speakers come from a vast array of perspectives and experiences, spanning in-house counsel, a certified licensing professional, a publisher of biotechnology magazine, a technology transfer and commercialization professional, a Director of Technology Transfer Officer of a division of NIH, a financial consultant and intellectual property professionals.
Speakers and Panelists
Keynote Speaker: Larry R. Miller, Ph.D. – Director, Global & Project Communications for FHI 360 and President/Consultant ISBC Solutions, LLC; former Director Business Operations, Global Drug Discovery, GlaxoSmithKline)
Stephen Auvil, Vice President – Technology Transfer & Commercialization, Maryland Technology Development Corporation
Akihiko Okuno, Partner, SK IP Law Firm, Japan
John Weatherspoon, Ph.D., Of Counsel, Stein McEwen LLP; General Counsel, Gene Facelift LLC
Scott Williams, AVA, CLP, Director, Invotex Group
Yali Friedman, Ph.D., Chief Editor and Publsher, Journal of Commercial Biotechnology
Ginette Serrero, Ph.D., Co-Founder and CEO of A&G Pharmaceutical, Inc.
Claire T. Driscoll, Director, Technology Transfer Office, National Human Genome Research Institute (NHGRI), NIH
Dennis Clarke, Of Counsel, Stein McEwen, LLP
Joseph Zito, Of Counsel, Stein McEwen, LLP
Complete details are available at http://www.smiplaw.com/seminar.cfmClick here for reuse options!
Copyright 2011 Biotechblog